| Name | 1-(2,3-dihydro-1,4-benzodioxin-6-yl)piperazine |
|---|---|
| Synonyms |
6-piperazinyl-2H,3H-benzo[e]1,4-dioxin
1-(2,3-Dihydro-benzo[1,4]dioxin-6-yl)-piperazine 1-(1,4-benzodioxan-6-yl)piperazine 6-piperazino-1,4-benzodioxane 1-(3,4-ETHYLENDIOXYPHENYL)PIPERAZINE 4-(2,3-dihydrobenzo-1,4-dioxin-6-yl)piperazine |
| Molecular Formula | C12H16N2O2 |
|---|---|
| Molecular Weight | 220.26800 |
| Exact Mass | 220.12100 |
| PSA | 33.73000 |
| LogP | 1.26120 |
| Hazard Codes | Xi |
|---|
|
~75%
148245-18-5 |
| Literature: Hodgetts; Kieltyka; Brodbeck; Tran; Wasley; Thurkauf Bioorganic and Medicinal Chemistry, 2001 , vol. 9, # 12 p. 3207 - 3213 |
|
~%
148245-18-5 |
| Literature: Neurogen Corporation Patent: US6177566 B1, 2001 ; US 6177566 B1 |
|
~%
148245-18-5 |
| Literature: Song, Jiho; Kim, Young Jin; Min, Kyung Hoon; Lee, Hyun-E; Kim, Su Yeon; Kim, Dong-Seok Bioorganic and Medicinal Chemistry Letters, 2012 , vol. 22, # 22 p. 6943 - 6946,4 |
| Precursor 3 | |
|---|---|
| DownStream 0 | |